UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oscillatory Breathing and Exercise Gas Exchange Abnormalities Prognosticate Early Mortality and Morbidity in Heart Failure

Journal of the American College of Cardiology, 2010-04, Vol.55 (17), p.1814-1823

2010

Volltextzugriff (PDF)

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

The American journal of cardiology, 2014-05, Vol.113 (9), p.1556-1560

2014

Volltextzugriff (PDF)

Drug Induced QTc Prolongation

The American journal of cardiology, 2017-01, Vol.119 (2), p.280-283

2017

Volltextzugriff (PDF)

Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial

Heart rhythm, 2019-05, Vol.16 (5), p.743-753

2019

Volltextzugriff (PDF)

HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection

Journal of the American College of Cardiology, 2012-08, Vol.60 (7), p.682-703

2012

Volltextzugriff (PDF)

Reply to the Editor—Out of Service Lead

Heart rhythm, 2013-05, Vol.10 (5), p.e68-e69

Beshai, John F., MD, FHRS

2013

Volltextzugriff (PDF)

Ranolazine Safely Decreases Ventricular and Atrial Fibrillation in Timothy Syndrome (LQT8)

Pacing and clinical electrophysiology, 2012-03, Vol.35 (3), p.e62-e64

2012

Volltextzugriff (PDF)

Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial

Journal of the American College of Cardiology, 2016-02, Vol.67 (6), p.674-683

2016

Volltextzugriff (PDF)

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance

Circulation. Cardiovascular imaging, 2016-01, Vol.9 (1), p.e003738

2016

Volltextzugriff (PDF)

Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS Complexes

The New England journal of medicine, 2007-12, Vol.357 (24), p.2461-2471

2007

Volltextzugriff (PDF)

Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia

Journal of the American College of Cardiology, 2016-02, Vol.67 (6), p.674-683

2016

Volltextzugriff (PDF)

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

Europace (London, England), 2012-09, Vol.14 (9), p.1236-1286

2012

Volltextzugriff (PDF)

Hybrid atrial fibrillation ablations and the increasing importance of the hybrid cardiovascular laboratory operating room

Annals of cardiac anaesthesia, 2015-07, Vol.18 (3), p.286-289

2015

Volltextzugriff (PDF)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure

Heart (British Cardiac Society), 2016-11, Vol.102 (21), p.1742-1749

2016

Volltextzugriff (PDF)

Out-of-service lead: Abnormal presentation at follow-up

Heart rhythm, 2013, Vol.10 (1), p.144-146

2013

Volltextzugriff (PDF)

Medtronic Sprint Fidelis lead recall: Determining the initial 5-year management cost to Medicare

Heart rhythm, 2011-08, Vol.8 (8), p.1192-1197

2011

Volltextzugriff (PDF)

Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction

Echocardiography (Mount Kisco, N.Y.), 2016-09, Vol.33 (9), p.1344-1352

2016

Volltextzugriff (PDF)

Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study

European journal of heart failure, 2011-11, Vol.13 (11), p.1231-1237

2011

Volltextzugriff (PDF)

HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons

Heart rhythm, 2012-08, Vol.9 (8), p.1344-1365

2012

Volltextzugriff (PDF)

ICD Lead Parameters, Performance, and Adverse Events following Continuous-Flow LVAD Implantation

Pacing and clinical electrophysiology, 2014-04, Vol.37 (4), p.464-472

2014

Volltextzugriff (PDF)

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction

Heart rhythm, 2006-08, Vol.3 (8), p.881-886

2006

Volltextzugriff (PDF)

Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial

Journal of interventional cardiac electrophysiology, 2015-08, Vol.43 (2), p.145-149

2015

Volltextzugriff (PDF)

Late potential at the high ventricular septal level in a patient with Brugada: possible mechanisms and clinical implications

Journal of electrocardiology, 2010-09, Vol.43 (5), p.459-462

2010

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(59)
Berichte
(1)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oscillatory Breathing and Exercise Gas Exchange Abnormalities Prognosticate Early Mortality and Morbidity in Heart Failure

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

Drug Induced QTc Prolongation

Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial

HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection

Reply to the Editor—Out of Service Lead

Ranolazine Safely Decreases Ventricular and Atrial Fibrillation in Timothy Syndrome (LQT8)

Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance

Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS Complexes

Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

Hybrid atrial fibrillation ablations and the increasing importance of the hybrid cardiovascular laboratory operating room

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure

Out-of-service lead: Abnormal presentation at follow-up

Medtronic Sprint Fidelis lead recall: Determining the initial 5-year management cost to Medicare

Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction

Heart Rhythm Society Expert Consensus Statement on Electrophysiology Laboratory Standards: Process, Protocols, Equipment, Personnel, and Safety

Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study

HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons

ICD Lead Parameters, Performance, and Adverse Events following Continuous-Flow LVAD Implantation

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction

Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial

Late potential at the high ventricular septal level in a patient with Brugada: possible mechanisms and clinical implications

Suchergebnisse filtern